SCHAUMBURG, Ill., April 25, 2016 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) a leading provider of affordable pharmaceuticals to the hospital market, today announced that it will release financial results for the 2016 first quarter pre-market on Tuesday, May 3, 2016 and will host a teleconference and webcast at 9 a.m. ET to review the results.

Interested parties may access the live call by dialing:

Within the United States: 877-293-5456

International: 707-287-9357

A live webcast of the teleconference will be available on the company's website at: http://investor.sagentpharma.com/events.cfm.

A replay of the presentation will be available on the Sagent website or by dialing:

Toll-Free: 855-859-2056

Passcode: 96375261

The replay will be available until May 17, 2016.

About Sagent Pharmaceuticals

Sagent Pharmaceuticals, Inc., founded in 2006, is a leading provider of affordable pharmaceuticals to the hospital market. Sagent has created a unique, global network of resources, comprising rapid development capabilities, sophisticated manufacturing and innovative drug delivery technologies, resulting in an extensive and rapidly expanding pharmaceutical product portfolio that fulfills the evolving needs of patients.

INVESTOR CONTACT:

Jonathon Singer, Sagent

847-908-1605

jsinger@sagentpharma.com

Sagent Pharmaceuticals Inc. published this content on 25 April 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 03 May 2016 12:48:04 UTC.

Original documenthttp://investor.sagentpharma.com/releasedetail.cfm?ReleaseID=968729

Public permalinkhttp://www.publicnow.com/view/02DB2A87EC7FF16430A52E703857BE2C676BC420